Are pre-frail and frail amyloid positive individuals eligible to Lecanemab? A cross-sectional analysis from the Cogfrail real-world cohort
处于衰弱前期和衰弱期且淀粉样蛋白阳性的患者是否符合Lecanemab的治疗条件？来自Cogfrail真实世界队列的横断面分析
期刊:Alzheimers Research & Therapy
影响因子:7.6
doi:10.1186/s13195-026-01966-0
Bellelli, Federico; Delrieu, Julien; van Kan, Gabor Abellan; Peluso, Alberta; Soriano, Gaëlle; Vellas, Bruno; Angioni, Davide; Sourdet, Sandrine
